References
- Nie, W., Wang, Y., Tian, X., Liu, J., Jin, Z., Xu, J., He, M., Shen, Q., Guo, H. & Luan, T. (2024). Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities. Molecules 29(17), 4193. DOI: 10.3390/molecules29174193.
- Ge, W., Chen, X., Han, F., Liu, Z., Wang, T., Wang, M., Chen, Y., Ding, Y. & Zhang, Q. (2018). Synthesis of Cucurbitacin B Derivatives as Potential Anti-Hepatocellular Carcinoma Agents. Molecules 23(12), 3345. DOI: 10.3390/molecules23123345.
- Tan, N., Li, Y., Ying, J. & Chen, W. (2024). Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows. J. Transl. Int. Med. 12(5), 452–465. DOI: 10.1515/jtim-2024-0019.
- Zhang, H., Zhao, B., Wei, H., Zeng, H., Sheng, D. & Zhang, Y. (2022). Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer. J. Ethnopharmacol. 287, 114915. DOI: 10.1016/j.jep.2021.114915.
- Li, Y., Yan, B. & He, S. (2023). Advances and challenges in the treatment of lung cancer. Biomed. Pharmacother. 169, 115891. DOI: 10.1016/j.biopha.2023.115891.
- Tian, B., Pang, Y., Gao, Y., Meng, Q., Xin, L., Sun, C., Tang, X., Wang, Y., Li, Z., Lin, H. & Wang, L. (2023). A pan-cancer analysis of the oncogenic role of Golgi transport 1B in human tumors. J. Transl. Int. Med. 11(4), 433–448. DOI: 10.2478/jtim-2023-0002.
- Turner, J., Pond, G.R., Tremblay, A., Johnston, M., Goss, G., Nicholas, G., Martel, S., Bhatia, R., Liu, G., Schmidt, H., Tammemagi, M.C., Puksa, S., Atkar-Khattra, S., Tsao, M.S., Lam, S. & Goffin, J.R. (2021). Risk Perception Among a Lung Cancer Screening Population. Chest 160(2), 718–730. DOI: 10.1016/j.chest.2021.02.050.
- Traeger, R.S., Woodcock, J., Tan, S., Shi, Z. & Vasquez-Vivar, J. (2025). Tetrahydrobiopterin as a rheostat of cell resistance to oxidant injury. Redox Biol. 79, 103447. DOI: 10.1016/j.redox.2024.103447.
- Luo, Z., Wan, R., Liu, S., Feng, X., Peng, Z., Wang, Q., Chen, S. & Shang, X. (2023). Mechanisms of exercise in the treatment of lung cancer–a mini-review. Front. Immunol. 14, 1244764. DOI: 10.3389/fimmu.2023.1244764.
- Janssen, E.M., Smith, I.P., Liu, X., Pierce, A., Huang, Q., Kalsekar, I., Vachani, A. & Mansfield, C. (2023). Patient Preferences for Lung Cancer Interception Therapy. JAMA Netw. Open 6(11), e2342681. DOI: 10.1001/jamanetworkopen.2023.42681.
- Bhattacharjee, J., Sarkar, A. & Panda, T.K. (2021). Recent development of alkali metal complex promoted iso-selective ring-opening polymerization of rac-Lactide. Curr. Opin. Green Sust. 31, 100545. DOI: 10.1016/j.cogsc.2021.100545.
- Ahmad, M.G., Balamurali, M.M. & Chanda, K. (2023). Click-derived multifunctional metal complexes for diverse applications. Chem. Soc. Rev. 52(15), 5051–5087. DOI: 10.1039/d3cs00343d.
- Chen, L.J., Zhao, X., Liu, Y.Y. & Yan, X.P. (2020). Macrophage membrane coated persistent luminescence nanoparticle@ MOF-derived mesoporous carbon core–shell nanocomposites for autofluorescence-free imaging-guided chemotherapy. J. Mater. Chem. B 8(35), 8071–8083. DOI: 10.1039/d0tb01272f.
- Sun, X., He, G., Xiong, C., Wang, C., Lian, X., Hu, L., Li, Z., Dalgarno, S.J., Yang, Y.W. & Tian, J. (2021). One-Pot Fabrication of Hollow Porphyrinic MOF Nanoparticles with Ultrahigh Drug Loading toward Controlled Delivery and Synergistic Cancer Therapy. ACS Appl. Mater. Interfaces 13(3), 3679–3693. DOI: 10.1021/acsami.0c20617.
- Das, B. & Gupta, P. (2024). Multimetallic transition metal complexes: Luminescent probes for biomolecule sensing, ion detection, imaging and therapeutic application. Coord. Chem. Rev. 504, 215656. DOI: 10.1016/j.ccr.2024.215656.
- Gaikwad, D., Sutar, R. & Patil, D. (2024). Polysaccharide mediated nanodrug delivery: A review. Int. J. Biol. Macromol. 261(1), 129547. DOI: 10.1016/j.ijbiomac.2024.129547.
- Srivastav, A.K., Rajput, P.K., Jaiswal, J., Yadav, U.C.S. & Kumar, U. (2024). In vitro and in silico investigation of glycyrrhizic acid encapsulated zein nanoparticles: A synergistic targeted drug delivery approach for breast cancer. Int. J. Biol. Macromol. 266(2), 131368. DOI: 10.1016/j.ijbiomac.2024.131368.
- Zhao, C., Pan, B., Wang, T., Yang, H., Vance, D., Li, X., Zhao, H., Hu, X., Yang, T., Chen, Z., Hao, L., Liu, T. & Wang, Y. (2023). Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment. Pharmaceutics 15(12), 2729. DOI: 10.3390/pharmaceutics15122729.
- Korpi, A., Anaya-Plaza, E., Välimäki, S. & Kostiainen, M. (2020). Highly ordered protein cage assemblies: A toolkit for new materials. WIREs Nanomed. Nanobiotechnol. 12(1), e1578. DOI: 10.1002/wnan.1578.
- Pauli, F.P., Freitas, C.S., Pereira, P.R., Magalhães, A., De Carvalho Da Silva, F., Paschoalin, V.M.F. & Ferreira, V.F. (2023). Exploring the Antimicrobial and Antitumoral Activities of Naphthoquinone-Grafted Chitosans. Polymers 15(6), 1430. DOI: 10.3390/polym15061430.
- Li, D.Q., Li, J., Dong, H.L., Li, X., Zhang, J.Q., Ramaswamy, S. & Xu, F. (2021). Pectin in biomedical and drug delivery applications: A review. Int. J. Biol. Macromol. 185, 49–65. DOI: 10.1016/j.ijbiomac.2021.06.088.
- Kong, W.Q., Gao, C.D., Hu, S.F., Ren, J.L., Zhao, L.H. & Sun, R.C. (2017). Xylan-Modified-Based Hydrogels with Temperature/pH Dual Sensitivity and Controllable Drug Delivery Behavior. Materials 10(3), 304. DOI: 10.3390/ma10030304.
- Agnes, M., Mazza, A., Malanga, M., Manet, I. (2024). Sculpturing the future of water-soluble cyclodextrin branched polymers in pharmaceutical applications. J. Mater. Chem. B 12(33), 7969–7976. DOI: 10.1039/d4tb01165a.
- Joyce, K., Fabra, G.T., Bozkurt, Y., Pandit, A. (2021). Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties. Signal Transduct. Tar. 6(1), 122. DOI: 10.1038/s41392-021-00512-8.